Table 5.
Direction of Activity | Species | Extract/Essential Oil | Part | Classification | Compounds | Model/Assay | Short Description of Performed Studies | References |
---|---|---|---|---|---|---|---|---|
Antitumor activity | A. abrotanum | Essential oil | Aerial part | Monoterpenoids | Borneol, cymene, camphor, terpineol, 1,8-cineole, and aromadendrene | In vitro | Decrease in the survival of neoplastic cells of the RD (rhabdomyosarcoma). The viability of RD cells after the application of the essential oil at concentrations of 25, 50, and 100 μg/mL was 29.679%, 20.833%, and 20.256%, respectively. | [168] |
Methanolic extract | Leaves | Phenolic acids | Chlorogenic and isochlorogenic acids | In vitro | Methanolic extract of A. abrotanum leaves in serial concentrations of 50, 100, 200, 300, and 400 µg/mL and its components (including chlorogenic acid and isochlorogenic acid) inhibits the proliferation of cells of the Jurkat line (T-lymphoblastic leukemia line, IC50 = 82.64 µg/mL), MCF-7 line (breast adenocarcinoma line, IC50 = 71.04 µg/mL), HeLa line (cervical adenocarcinoma line, IC50 = 49.97 µg/mL), and HT-29 line (colorectal adenocarcinoma line, IC50 = 54.75 µg/mL). | [20] | ||
A. dracunculus | hexane, ethyl acetate, acetone, ethanol, acetonitrile and supercritical carbon dioxide (scCO2) | Leaves | Polyphenols, alkamides | nt * | In vitro (mouse lymphoma L5178YD cells) | Inhibition of the proliferation of mouse lymphoma cells (L5178YD) due to the presence of polyphenols and alkamides in leaf extracts. In the control group the tumor cell count was 17.969 × 106, the acetonitrile extract from A. dracunculus leaves reduced the cell count to 0.1 × 106. | [21] | |
Alleviating allergy symptoms | A. abrotanum | Essential oil and isolated flavonoids | Aerial part | Monoterpenoids, flavonoids | 1,8-Cineole, davanone, linalool, centaureidine dimethylether, casticin and quercetin | In vivo | Relief of symptoms of allergic rhinitis with possible concomitant allergic conjunctivitis, symptoms of bronchial obstruction, and symptoms of exercise-induced asthma by using a nasal spray with a mixture of essential oils and flavonoids present in A. abrotanum. | [117] |
Digestion-stimulating activity | A. absinthium | Ethanol | Herb | nt | nt | In vivo | Change in postprandial hemodynamics in the gastric digestive phase with increased hyperemia, probably due to the effects of bitter compounds contained in the herb of the plant. | [19] |
Appetite-stimulating activity | A. absinthium | nt | Aerial part | nt | nt | In vivo | Enrichment of sheep fodder with silage containing A. absinthium increases the amount of fodder consumed, improves digestion, induces nitrogen retention, and has a positive effect on the development of microorganisms involved in nitrogen assimilation. | [180] |
nt | Aerial part | nt | nt | In vivo | Improvement in nutrient supply and digestion, faster growth, improvement in carcass quality, and the amount of fatty acids among Hanwoo steers. | [181] | ||
Antiulcer activity | A. absinthium | carbon tetrachloride, chloroform, methanol, ethanol, hexane | Aerial part and root | nt | nt | In vivo (rats) | Decrease in gastric juice volume, reduction in gastric acid and pepsin secretion, and decrease in the digestion rate. | [182] |
Hepatoprotective activity | A. absinthium | Hydro-methanol | Herb | nt | nt | In vivo (rats) | A. absinthium extracts (in dose 500 mg/kg) inhibit liver microsomal enzymes (20%) that are responsible for the metabolism of xenobiotics. | [183] |
Methanol | Herb | nt | nt | In vivo (rats) | Methanolic extracts from the herb of the plant (in dose 50 mg/kg) protect liver cells by reducing ALAT (alanine aminotransferase) and ASPAT (aspartate aminotransferase) levels and by reducing oxidative damage. | [13] | ||
Aqueous | Herb | nt | nt | In vivo (mice) | Protection of the liver due to the immunomodulatory and/or antioxidant properties of A. absinthium (in dose 500, 100, or 200 mg/kg body weight/day). | [184] | ||
A. dracunculus | Hydro-ethanol | Herb | nt | nt | In vivo (rats) | The extract (at dose 50, 100, or 200 mg/kg) decreased the levels of ALAT, ASPAT, alkaline phosphatase, and total bilirubin and increased total protein levels. | [40] | |
A. vulgaris | Hydro-ethanol | Aerial part | nt | nt | In vivo (mice) | Prophylactic protective effect limiting inflammation, cellular edema, apoptotic cell count, and hyperemia of the hepatic parenchyma of hydro-ethanolic extract (at dose 600 mg/kg). | [209] | |
Antispasmolytic activity | A. vulgaris | Chloroform and methanol | Herb | Sesquiterpenoids | Yomogin and 1,2,3,4-diepoxy-11(13)-eudesmen-12,8-olide | In vivo (guinea pigs) | Antagonism toward H1 histamine receptors. | [138,142] |
Anthelmintic activity | A. absinthium | Aqueous and an ethanolic | Aerial part | nt | nt | In vivo (sheep) | Extracts from A. absinthium (in dose 2 g/kg body weight) cause paralysis and/or death of Haemonchus contortus nematodes and reduce (80.49%) the number of the parasite’s eggs in the host’s feces. | [185] |
Essential oil | Aerial part | nt | nt | In vivo (mice) | Lethal effect on Trichinella spiralis larvae. | [86,186] | ||
Ethanolic | Herb | nt | nt | In vivo (rabbits) | Lethal effect of A. absinthium ethanolic extract on Ascaris suum eggs and Trichostrongylus colubriformis larvae. | [187] | ||
Ethanolic extract | Aerial part | nt | nt | In vivo (sheep), in vitro (parasite motility inhibition test) | Lethal effect on H. contortus tested in vivo; reduction in its mobility in vitro. | [188] | ||
A. vulgaris | Methanol | Herb | nt | nt | In vivo (rats) | Extract (at dose 300 mg/kg) inhibited activity against T. spiralis by 75.6% and 63.5% in the tongue, 53.4% and 37.7% in the diaphragm, 67.8% and 46.2% in the quadriceps, and 66.7% and 60.5% in the biceps–triceps muscles of rats. | [186] | |
Antiprotozoal activity | A. absinthium | Aqueous and ethanolic extracts | Aerial part | nt | nt | In vitro (mice) | Lethal effect of aqueous and ethanolic extracts from A. absinthium on Plasmodium berghei (in dose 74 mg/kg). | [25] |
Hydro-ethanolic | Herb | nt | nt | In vitro (chloroquine-resistant (K1) and chloroquine-sensitive (CY27) strains of Plasmodium berghei) | Lethal effect of the hydro-ethanolic extract P. berghei. IC50 = 0.46 μg/mL for the K1 strain and IC50 = 0.195 μg/mL for the CY27. | [26] | ||
nt | Herb powdered | nt | nt | In vivo (human) | Lethal effect of capsuled powdered herb of A. absinthium in dose 500 mg on Entamoeba histolytica. | [30] | ||
Essential oil | Aerial part | nt | nt | In vitro | Lethal activity against the promastigotes and amastigotes forms of the protozoa Leishmania aethiopica and Leishmania donovani. MIC for both microorganisms in the promastigote form was 0.1565 μL/mL. | [32] | ||
Ethanol | Aerial part | Flavonoids, sesquiterpenoid lactone | Artemetin, casticin, hydroxypelenolide | In vitro | Lethal activity in vitro against Leishmania infantum and Trypanosoma cruzi | [33,34] | ||
Essential oil | Aerial part | Sesquiterpenoids | (E)-Caryophyllene and 3,6-dihydrochamazulene | In vitro | Lethal effect of the essential oil on T. cruzi and on Trichomonas vaginalis. The compounds likely to be responsible for this activity are (E)-caryophyllene and 3,6-dihydrochamazulene. | [35] | ||
Aqueous and ethanolic | Aerial part | Sesquiterpenoids lactones | Artemisinin, dihydroartemisinin | In vitro | Inhibition (100%) of Naegleria fowleri growth by sesquiterpenoid lactones from A. absinthium. | [36] | ||
Aqueous | Aerial part | nt | nt | In vitro | Inhibition (88.9%) of A. absinthium aqueous extract against Plasmodium falciparum. | [37] | ||
A. annua | Methanol, ethanol, aqueous | Herb | Sesquiterpene lactone | Artemisinin | In vivo/In vitro | Lethal activity against Artemisia castellani of artemisinin and methanolic, ethanolic, and aqueous extracts from A. annua herb. | [27] | |
n-Hexane, ethanol, and water | Leaves and seeds | nt | nt | In vitro | Compounds present in A. annua seed and leaf extracts have lethal activity against L. donovani. | [29] | ||
A. d racunculus | Hydro-ethanol | Herb | nt | nt | In vitro | The extract (at dose (100–1000 μg/mL) inhibited the development of the promastigote form of Leishmania major. The recorded MIC values of the extract after 24 h, 48 h and 72 h were: 962.03, 688.36 and 585.51 μg/mL. | [28] | |
Immunostimulating activity | A. absinthium | Ethanolic | Herb | nt | nt | In vivo (mice) | Induction of dendritic cell maturation by increasing the level of CD40 surface expression and by induction of cytokines. It was found that at 100 μg/mL extract the proliferation of T-lymphocytes was reduced by 78.2% relative to the control. | [189] |
nt | Herb | Polysaccharides | nt | In vivo (mice) | Induction of TH1 immune response and stimulation of nitric oxide production by macrophages. | [190] | ||
Immunosuppressive activity | A. annua | Ethanol | Herb | nt | nt | In vitro/In vivo | Inhibition of lymphocyte proliferation and reduction in IgG, IgG1, and IgG2b antibody levels after the administration of A. annua whole-plant extract (at dose 0.25, 0.5, and 1. 0 mg). | [91] |
nt | Herb | Sesquiterpene lactone | Artemisinin | In vivo (mice) | Artemisinin obtained from A. annua inhibits late-type hypersensitivity response and has a suppressive effect on calmodulin responsible for activation of T lymphocytes. | [198] | ||
A. d racunculus | Aqueous | Herb | nt | nt | In vivo (mice) | The extract (at dose 100 mg/kg) reduced IL-17 (interleukin 17) and IFN-γ (interferon gamma) production and intensification of the phagocytosis process carried out by macrophages. | [149] | |
Aqueous | Herb | nt | nt | In vivo (mice) | Lowering of IL-17 and IL-23 (interleukin-23) levels and reduction in the infiltration of leukocytes into brain cells. | [204] | ||
Hydro-ethanol | Leaves | nt | nt | In vivo (mice) | Increased neutrophil levels and decreased lymphocyte levels after intraperitoneal administration of the hydroethanolic extract from the leaves (at dose 200 mg/kg). | [205] | ||
Cytotoxic activity | A. absinthium | Methanol | Leaves | nt | nt | In vitro | Inhibition of proliferation of breast cancer cells of MDA-MB-231 (50% at 20 g/mL) and MCF-7 lines (50%, at 25 g/mL). | [17] |
Essential oil | Aerial part | Sesquiterpenoids | (E)-Caryophyllene, germacrene D | In vitro | The essential oil, in particular (E)-caryophyllene and/or germacrene D, is toxic to tumor lines A548, NCI-H292, HCT116, MCF-7, and SK-MEL-5. | [18] | ||
A. annua | Ethyl acetate | Aerial part | Polyphenols | Caffeic acid, syringic aldehyde, dicaffeoylquinic acid isomer, quercetin 3-O-galactoside, dicaffeoylquinic acid isomer, mearnsetin 3-O-hexoside isomer, kaempferol 3-O-glucoside, quercetin 3-O-glucoside, ferulic acid, caffeoylferuloylquinic acid isomer, isorhamnetin 3-O-glucoside, diosmetin 7-O-glucoside, luteolin 7-O-glucoside, diferuloylquinic acid, quercetin, dicaffeoylferuloylquinic acid isomer, 3-O-methylquercetagetin, luteolin, 8-methoxykaempferol, 3,5-dimethoxyquercetagetin, caffeoyldiferuloyl quinic acid, kaempferol, 3,5-dihydroxy-6,7,4′-trimethoxyflavone, and 3,5-dihydroxy-6,7,3′,4′-tetramethoxyflavone | In vitro | Polyphenols present in A. annua inhibit adhesion of cancer cells to endothelial cells and inhibit epithelial–mesenchymal transition. | [123] | |
nt | Herb | Sesquiterpenoid lactone | Artemisinin | In vivo | Regression of prostate cancer in a patient treated (at dose 5 mg/day) with capsules containing a concentrate with A. annua and bicalutamide. | [199] | ||
Methanol | Leaves | nt | nt | In vitro | Methanolic extract from A. annua leaves collected in Egypt showed significant cytotoxic activity against MCF-7 human breast adenocarcinoma cell line, human lung cancer cell line, and Chinese hamster ovary (CHO) cell line. | [201] | ||
A. vulgaris | Methanol | Aerial part | nt | nt | In vitro | Inhibition of tumor cell growth in cancer cell lines: MCF-7 (IC50 = 190 ng/mL), HeLa (IC50 = 284 ng/mL), A7R5 (IC50 = 382 ng/mL), 293T (IC50 = 317 ng/mL), and SW-480 (IC50 = 778 ng/mL). | [210,211,212] | |
Analgesic activity | A. absinthium | Methanolic | Herb | nt | nt | In vivo (mice) | Reduction in temperature-induced pain in mice at doses of 300 mg/kg, 500 mg/kg or 1000 mg/kg. | [191] |
Essential oil/Aqueous | Aerial part | nt | nt | In vivo (mice) | Reduction in episodes in the writhing test and delay in pain response in the hot plate test in mice after the administration of A. absinthium essential oil (at doses of 2, 4, or 8 mg/kg) or aqueous extract (50, 100, or 200 mg/kg). | [122] | ||
A. annua | Essential oil | Herb | Monoterpenoids | Camphor, 1,8-cineol, and α-pinene | In vivo (mice) | Administration of essential oil (at dose 400 mg/kg) from A. annua herb, camphor, 1,8-cineol, and α-pinene in mice reduces (57%) writhing episodes caused by acetic acid. | [93] | |
A. vulgaris | Hydro-ethanol | Aerial part | Flavonoids, phenolic acids | Rutoside, hydroxybenzoic acid derivatives, and caffeic acid and its derivatives. | In vivo (mice) | Mild peripheral antinociceptive effect of extract (at dose 100 and 250 mg/kg). | [142] | |
Inhibiting the activity of carbonic anhydrase I and II | A. dracunculus | Dichloromethane | Herb | Phenylpropanoid derivatives, sterols, coumarin | trans-Anethole, stigmasterol, herniarin, (2E,4E)-N-isobutylundeca-2,4-diene-8,10-diynamide, (2E,4E)-1-(piperidin-1-yl)undeca-2,4-diene-8,10-diyn-1-one and 1-(4’-methoxyphenyl)-1,2,3-trihydroxypropane | In vitro | Compounds present in herbal extracts reduce the activity of carbonic anhydrase I (hCA I) and II (hCA II) (IC50 = 0.02 μg/mL for hCA I, and IC50 = 0.31 μg/mL for hCA II). | [216] |
Neuroprotective activity | A. absinthium | Methanol | Aerial part | nt | nt | In vivo (rats) | Methanolic extract (at dose 100 and 200 mg/kg) from A. absinthium, because of its antioxidant potential, reduces brain damage, inhibits lipid peroxidation, and restores the activity of enzymes involved in reducing oxidative stress. | [14] |
Aqueous | Herb | nt | nt | In vivo (rats) | Protective effect of A. absinthium aqueous extract (at dose 200 mg/L) on glial cells and the dopaminergic system when exposed to lead. | [15] | ||
Herb | Sesquiterpenoid dimer | Caruifolin D | In vitro (BV2 microglial cells) | Caruifolin D in Absinthii herba inhibits the production of proinflammatory microglia mediators and reactive oxygen species and also inhibits protein C kinase and stress-activated kinases. | [130] | |||
Antidepressant activity | A. absinthium | Methanol | Aerial part | nt | nt | In vivo (mice) | Shortening of the period of mouse immobility in the forced swim test (at dose 1000 mg/kg) and in the tail suspension test (at dose 500 mg/kg). | [16] |
A. dracunculus | Ethanol | Herb | nt | nt | In vivo (mice) | Increased resistance to stressful situations and reduction in stress-related levels of inflammatory cytokines. | [206] | |
Ethanol | Herb | Phenolic acids, flavonoids | Chlorogenic acid, caffeic acid or luteolin and quercetin | In vivo (mice) | Phenolic compounds and flavonoids contained in the A. dracunculus herb extract (at dose dose of 200 mg/kg) reduce the immobility response time in mice in the writhing test and in the forced swim test. | [114] | ||
Ethanol | Herb | Coumarins | Herniarin, skimmin c | In vitro | Mild inhibition of hMAO-A (human monoamine oxidase A) and hMAO-B (human monoamine oxidase B) by extracts of A. dracunculus and compounds. Herniarin and skimmin c showed the inhibitory effects against hMAO A (IC50 = 51.76 and 73.47 μM, respectively) and hMAO B (IC50 = 0.84 and 1.63 mM, respectively). | [112] | ||
Procognitive activity | A. absinthium | Ethanol | Aerial part | nt | nt | In vitro (human cortical brain cells) | Extract in concentration 29 mg/mL had affinity for human muscarinic (99.8%) and nicotinic receptors (99.8%) responsible for cognitive functions. | [38] |
Neurotrophic activity | A. absinthium | Methanol, ethanol and aqueous | Aerial part | nt | nt | In vitro (PC12D cells (cell line of rat pheochromocytoma tumor) | Methanolic, ethanolic, and aqueous extracts from A. absinthium induce the nerve growth factor, which stimulates development of neurites. | [217] |
Nephroprotective activity | A. annua | Essential oil | Aerial part | nt | nt | In vivo (rats) | Administration of A. annua essential oil to rats exposed to carbon tetrachloride prevents kidney damage. | [93] |
Stabilizing cell membrane activity | A. absinthium | Hydroalcoholic | Aerial part | nt | nt | In vitro | Hydroalcoholic extract from A. absinthium prevents hemolysis of erythrocytes. | [218] |
Auxiliary action in obesity treatment | A. annua | Essential oil | Aerial part | nt | nt | In vitro | Reduction in fat droplet accumulation and inhibition of PPARγ (peroxisome proliferator- activated receptor gamma), C/EBPα (CCAAT/enhancer-binding protein), SREBP-1c (Sterol regulatory element-binding protein 1), FAS, and ACC (Acetyl-CoA carboxylase) protein expression under the influence of A. annua essential oil. | [202] |
Hydro-ethanol | Leaves | nt | nt | In vivo (mice) | Reduction in insulin resistance, liver steatosis, and fibrosis. Lowering the levels of SREBP-1c, ChREBP (carbohydrate-responsive element-binding protein), and COX-2 (cyclooxygenase-2). Inhibition of TGF-β1 and connective tissue growth factor. | [203] | ||
Hypoglycemic activity | A. dracunculus | Ethanol | Herb | nt | nt | In vivo | Encapsulated ethanolic extract of A. dracunculus (at dose 1000 mg for 90 days) decrease in glycated hemoglobin (5.8% in the control group, 5.6% in the test group), area under the curve for insulin (56.136 to 27.426 pmol/L in the control group, 44.472 to 23.370 pmol/L in the test group), total insulin secretion (0.45 to 0.23 in the control group, 0.35 to 0.18 in the test group), and systolic blood pressure (120 mm Hg in the control group, 113 mmHg in the test group), and increase in HDL-C. | [207] |
Hypolipemic activity | A. vulgaris | Aqueous | Root | nt | nt | In vivo (rat) | Normalized serum lipid profile, a significant increase in paraoxonase-1 activity, and decrease in serum malondialdehyde, nitric oxide, and tumor necrosis factor-α levels and in hydroxymethylglutaryl-CoA reductase activity. Lowering total cholesterol, triglycerides, LDL (low-density lipoprotein), and VLDL (very low density lipoprotein), and increasing HDL (high density lipoprotein) and atherogenicity indicator (aqueous extract of A. vulgaris roots). |
[213,214] |
Antihypertensive activity | A. vulgaris | Aqueous and chloroform | Aerial part | nt | nt | In vivo (rats) | A 10% solution of the aqueous extract inhibiting the hypertensive effect of noradrenaline. | [215] |
Bronchodilatory activity | A. vulgaris | Methanol | Aerial part | Alkaloids, coumarins, flavonoids, saponins, sterols, tannins, and terpenoids | nt | In vivo (rabbit jejunum and guinea pig trachea) | Anticholinergic and Ca2+ antagonist mechanisms. Histamine H1 antagonism in the ileum and trachea. | [138,208] |
Normalizing the profile of thyroid hormones | A. dracunculus | Aqueous | Herb | nt | nt | In vivo (rats) | Extract (at dose 300 mg/kg) caused increase in thyroxine and triiodothyronine levels, decrease in thyrotropin levels, increase in total antioxidant capacity, increase in glutathione, and decrease in malondialdehyde levels. | [22] |
Estrogenic activity | A. vulgaris | Ethyl acetate | Aerial part | Flavonoids | Eriodictyol and apigenin | In vivo (rats) | Antagonism toward the estrogen receptor and activation of gene transcription. Induction of gene transcription by eriodictyol and apigenin. Anti-implantation activity and estrogenic activity on female Wistar rats. | [23,24] |
Insect repellent activity | A. abrotanum | Toluene extract | Herb | Monoterpenoids, coumarins, phenolic acids | Camphor, coumarin and thujyl alcohol, chlorogenic acid and caffeic acid | In vivo | Toluene extract from the herb A. abrotanum and the individual components of the extract showed an insect repellent effect against Ixodes ricinus and Aedes aegypti. After 4 and 8 h from the time of applying the ethanolic suspension of the toluene extract from the herb A. abrotanum, the recorded repellency rates were, respectively, 69.1% and 56.8% against Ixodes ricinus, and 100% and 86.7% against Aedes aegypti. | [116] |
A. dracunculus | Essential oil | Herb | nt | nt | In vitro | Inhibition of Calliphora vomitoria egg laying on fresh beef, on which the essential oil of A. dracunculus herb (at dose 0.05 μL/cm2) was applied. | [96] | |
Essential oil | Herb | nt | nt | In vitro | Larvacidal effect against Anopheles stephensi under the influence of nanoemulsion of A. dracunculus essential oil (consisting of 0.35% tarragon oil, 10% of Tween 20 and deionized water). | [102] | ||
Anti-animal parasites activity | A. abrotanum | Reduction in the number of eggs of Hymenolepis nana (dwarf tapeworm), Syphacia obvelata, and Aspiculuris tetraptera (rodent pinworms) in the feces of mice after administration of ethanolic extract from A. abrotanum leaves. | [192] | |||||
A. annua | Water, 0.1% sodium bicarbonate solution, dichloromethane, and methanol | Leaves | Sesquiterpenoid lactones | Artemisinin | In vivo | Extracts from A. annua leaves inhibit the growth of larvae and the hatching of eggs of Haemnochus contortus (parasite of sheep and goats). | [118] | |
Antiplasmodial activity | A. abrotanum | Ethanol/water (1/1) | Leaves | nt | nt | In vitro/Hemolysis assay | Notable antiprotozoal activity against P. falciparum under the influence of A. abrotanum-AgNPs in concentration ranging from 0.6 to 7.5 µg/mL. The inhibition dependent on concentration was 50%, 90%, and 99%. | [219] |
Antimalarial activity | A. annua | Methanol | Herb | nt | nt | In vivo | Improvement in malaria symptoms after treating patients with infusion of A. annua herb. Inactivation of protozoan calcium pump. | [193] |
Hydro-ethanol and aqueous | Leaves | nt | nt | In vivo | Lethal activity of hydroethanolic and aqueous extracts from A. annua leaves (at dose 20 mg/kg) against P. falciparum and P. berghei. | [194] | ||
nt | Herb | Sesquiterpenoid lactones | Artemisinin | In vitro | Interference of artemisinin with protein metabolism and mitochondrial activity of Plasmodium spp. protozoa. | [195] | ||
nt | Leaves | Sesquiterpenoid lactones | Artemisinin | In vitro | Synergism of action of artemisinin and other compounds present in A. annua leaves against P. falciparum. | [131] | ||
A. vulgaris | Ethanol | Leaves | nt | nt | In vitro | Activity against Plasmodium yoelii and P. berghei. The extract at doses of 500, 750, and 1000 mg/kg significantly inhibited parasitemia by 79.3%, 79.6%, and 87.3%, respectively. | [220,221] |
* nt—not tested.